Recombinant Human ACVR1/ALK-2 Protein
Beta LifeScience
SKU/CAT #: BLK-00140P-100UG
Human ACVR1 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Human ACVR1/ALK-2 Protein
Beta LifeScience
SKU/CAT #: BLK-00140P-100UG
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
| Description | Recombinant Human ACVR1/ALK-2 Protein is expressed from HEK293 with hFc tag at the C-terminus.It contains Met21-Glu123. |
| Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
| Accession | Q04771 |
| Target Symbol | ACVR1/ALK-2 |
| Species | Human |
| Expression System | HEK293 |
| Tag | C-hFc |
| Expression Range | Met21-Glu123 |
| Mol. Weight | The protein has a predicted MW of 37.43 kDa. Due to glycosylation, the protein migrates to 45-55 kDa based on Tris-Bis PAGE result. |
| Form | Lyophilized |
| Formulation | Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
| Endotoxin | Less than 1EU per ug by the LAL method. |
| Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
| Shipping | Shipped at ambient temperature. |
| Gene Background | Activin A receptor type I (ACVR1), a transmembrane serine/threonine kinase, belongs to the transforming growth factor-β superfamily, which signals via phosphorylating the downstream effectors and SMAD transcription factors. Genetic variation in ACVR1 has been associated with a rare disease, fibrodysplasia ossificans progressive, and its somatic alteration is reported in rare cancer diffuse intrinsic pontine glioma. |
